The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
893485510 8934855 10 F 2010 20160711 20121129 20160714 EXP US-009507513-1211USA011497 MERCK 0.00 M Y 68.27000 KG 20160714 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
893485510 8934855 1 PS PROPECIA FINASTERIDE 1 Oral 1 MG, UNK U 20788 1 MG FILM-COATED TABLET
893485510 8934855 2 SS PROPECIA FINASTERIDE 1 Oral 1.25 MG U 20788 FILM-COATED TABLET QD
893485510 8934855 3 SS PROPECIA FINASTERIDE 1 Oral 1.25 MG QOD U 20788 FILM-COATED TABLET QOD
893485510 8934855 4 SS PROPECIA FINASTERIDE 1 Oral 0.5 QOD U 20788 FILM-COATED TABLET QOD
893485510 8934855 5 SS FINASTERIDE. FINASTERIDE 1 Oral 5 MG, 1/4 TAB, 1.25MG DAILY U 0 5 MG FILM-COATED TABLET QD
893485510 8934855 6 C ROGAINE MINOXIDIL 1 Topical 5%, 1 ML, BID U 0 1 ML BID
893485510 8934855 7 C ROGAINE MINOXIDIL 1 2%, 1 ML, BID U 0 1 ML BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
893485510 8934855 1 Androgenetic alopecia
893485510 8934855 5 Diffuse alopecia
893485510 8934855 6 Alopecia

Outcome of event

Event ID CASEID OUTC COD
893485510 8934855 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
893485510 8934855 Adverse event
893485510 8934855 Anal fissure
893485510 8934855 Angiopathy
893485510 8934855 Anorgasmia
893485510 8934855 Anxiety
893485510 8934855 Attention deficit/hyperactivity disorder
893485510 8934855 Blood oestrogen increased
893485510 8934855 Blood testosterone decreased
893485510 8934855 Blood testosterone increased
893485510 8934855 Circumcision
893485510 8934855 Cognitive disorder
893485510 8934855 Depression
893485510 8934855 Dihydrotestosterone decreased
893485510 8934855 Disturbance in sexual arousal
893485510 8934855 Dysuria
893485510 8934855 Erectile dysfunction
893485510 8934855 Fatigue
893485510 8934855 Febrile convulsion
893485510 8934855 H1N1 influenza
893485510 8934855 Hyperhidrosis
893485510 8934855 Hypotrichosis
893485510 8934855 Infectious mononucleosis
893485510 8934855 Libido decreased
893485510 8934855 Male orgasmic disorder
893485510 8934855 Mental disorder
893485510 8934855 Micturition urgency
893485510 8934855 Peripheral sensory neuropathy
893485510 8934855 Pertussis
893485510 8934855 Pollakiuria
893485510 8934855 Proctalgia
893485510 8934855 Semen liquefaction
893485510 8934855 Sexual dysfunction
893485510 8934855 Testicular disorder
893485510 8934855 Testicular pain
893485510 8934855 Urinary retention
893485510 8934855 Wrong technique in product usage process

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
893485510 8934855 1 20100805 20101123 0
893485510 8934855 2 201003 20101125 0
893485510 8934855 5 20100305 20100723 0
893485510 8934855 6 2010 201201 0
893485510 8934855 7 20120302 0